Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?

Biomedicines · 2025 · PMC12292612 · PMID 40722592

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In a meta-analysis of the LEAD program, treatment with liraglutide improved liver enzymes and showed a trend towards the improvement of hepatic steatosis compared to placebo [ 77 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.